TY - JOUR
T1 - Clinical risk factors influencing dental developmental disturbances in childhood cancer survivors
AU - Kang, Chung Min
AU - Hahn, Seung Min
AU - Kim, Hyo Sun
AU - Lyu, Chuhl Joo
AU - Lee, Jae Ho
AU - Lee, Jinae
AU - Han, Jung Woo
N1 - Publisher Copyright:
©2018 by the Korean Cancer Association.
PY - 2018/7/1
Y1 - 2018/7/1
N2 - Purpose Although studies regarding dental developmental disturbances after childhood cancer treatment have increased, they have many limitations. Studies analyzing the significance of independent clinical risk factors with regard to the dental health status are also rare. We aimed to investigate the risk factors for dental developmental disturbances, particularly severe disturbances, in childhood cancer survivors (CCS). Materials and Methods Oral examinations and retrospective reviews of medical and panoramic radiographs were performed for 196 CCS (mean age, 15.6 years). Cancer type, age at diagnosis, treatment modality, type and accumulated dose of administered drugs, and dose and site of radiation were recorded. Dental developmental disturbances were diagnosed using panoramic radiographs and graded for severity according to the Modified Dental Defect Index (MDDI). Descriptive statistics and multivariate analyses were performed to determine the association between dental abnormalities and clinical factors. Results In total, 109 CCS (55.6%) exhibited at least one dental anomaly, and the median value of MDDI was 2.5. Microdontia (30.6%) was the most prevalent anomaly, followed by tooth agenesis (20.4%), V-shaped roots (14.8%), and taurodontism (10.2%). Multivariate analysis revealed that a young age at diagnosis (≤ 3 years), a history of hematopoietic stem cell transplantation, the use of multiple classes of chemotherapeutic agents (≥ 4 classes), and the use of heavy metal agents were significant risk factors for severe dental disturbances. Conclusion CCS with any of the above risk factors for severe developmental disturbances should be comprehensively followed up to minimize adverse consequences to their dental development and preserve their future dental health.
AB - Purpose Although studies regarding dental developmental disturbances after childhood cancer treatment have increased, they have many limitations. Studies analyzing the significance of independent clinical risk factors with regard to the dental health status are also rare. We aimed to investigate the risk factors for dental developmental disturbances, particularly severe disturbances, in childhood cancer survivors (CCS). Materials and Methods Oral examinations and retrospective reviews of medical and panoramic radiographs were performed for 196 CCS (mean age, 15.6 years). Cancer type, age at diagnosis, treatment modality, type and accumulated dose of administered drugs, and dose and site of radiation were recorded. Dental developmental disturbances were diagnosed using panoramic radiographs and graded for severity according to the Modified Dental Defect Index (MDDI). Descriptive statistics and multivariate analyses were performed to determine the association between dental abnormalities and clinical factors. Results In total, 109 CCS (55.6%) exhibited at least one dental anomaly, and the median value of MDDI was 2.5. Microdontia (30.6%) was the most prevalent anomaly, followed by tooth agenesis (20.4%), V-shaped roots (14.8%), and taurodontism (10.2%). Multivariate analysis revealed that a young age at diagnosis (≤ 3 years), a history of hematopoietic stem cell transplantation, the use of multiple classes of chemotherapeutic agents (≥ 4 classes), and the use of heavy metal agents were significant risk factors for severe dental disturbances. Conclusion CCS with any of the above risk factors for severe developmental disturbances should be comprehensively followed up to minimize adverse consequences to their dental development and preserve their future dental health.
UR - http://www.scopus.com/inward/record.url?scp=85049795521&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049795521&partnerID=8YFLogxK
U2 - 10.4143/crt.2017.296
DO - 10.4143/crt.2017.296
M3 - Article
C2 - 29020731
AN - SCOPUS:85049795521
SN - 1598-2998
VL - 50
SP - 926
EP - 935
JO - Cancer Research and Treatment
JF - Cancer Research and Treatment
IS - 3
ER -